ATE371641T1 - Hydroxy-tetrahydro-naphtalenylharnstoff-derivat - Google Patents
Hydroxy-tetrahydro-naphtalenylharnstoff-derivatInfo
- Publication number
- ATE371641T1 ATE371641T1 AT03722554T AT03722554T ATE371641T1 AT E371641 T1 ATE371641 T1 AT E371641T1 AT 03722554 T AT03722554 T AT 03722554T AT 03722554 T AT03722554 T AT 03722554T AT E371641 T1 ATE371641 T1 AT E371641T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydro
- pain
- naphtalenyl
- hydroxy
- useful
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 208000028389 Nerve injury Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- 208000004550 Postoperative Pain Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000008764 nerve damage Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE371641T1 true ATE371641T1 (de) | 2007-09-15 |
Family
ID=29422108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03722554T ATE371641T1 (de) | 2002-05-08 | 2003-04-28 | Hydroxy-tetrahydro-naphtalenylharnstoff-derivat |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7612113B2 (de) |
| EP (1) | EP1506167B1 (de) |
| JP (1) | JP4335131B2 (de) |
| CN (1) | CN1307150C (de) |
| AT (1) | ATE371641T1 (de) |
| AU (1) | AU2003229734B2 (de) |
| BR (1) | BR0309940A (de) |
| CA (1) | CA2487238C (de) |
| DE (1) | DE60315973T2 (de) |
| DK (1) | DK1506167T3 (de) |
| ES (1) | ES2292959T3 (de) |
| HK (1) | HK1082946A1 (de) |
| HR (1) | HRP20041167A2 (de) |
| IL (1) | IL165004A (de) |
| MX (1) | MXPA04010938A (de) |
| NO (1) | NO20045359L (de) |
| NZ (1) | NZ536418A (de) |
| PL (1) | PL210288B1 (de) |
| RU (1) | RU2331635C2 (de) |
| TW (1) | TWI271396B (de) |
| WO (1) | WO2003095420A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003273856A1 (en) * | 2002-09-24 | 2004-04-19 | Bayer Healthcare Ag | Vr1 antagonists for the treatment of urological disorders |
| ES2291725T3 (es) * | 2002-12-06 | 2008-03-01 | Xention Limited | Derivados de tetrahidro-naftaleno. |
| ES2311744T3 (es) * | 2002-12-09 | 2009-02-16 | Xention Limited | Derivados de tetrahidronaftaleno como antagonistas del receptor vainilloide. |
| WO2005035471A1 (ja) | 2003-10-14 | 2005-04-21 | Ajinomoto Co., Inc. | エーテル誘導体 |
| CA2542494A1 (en) * | 2003-10-15 | 2005-05-06 | Bayer Healthcare Ag | Tetrahydro-naphthalene and urea derivatives |
| WO2005044802A2 (en) * | 2003-11-08 | 2005-05-19 | Bayer Healthcare Ag | Tetrahydro-quinolinylurea derivatives as vrl antagonists |
| WO2005095329A1 (en) * | 2004-03-31 | 2005-10-13 | Pfizer Japan Inc. | Substituted benzamide compounds as vr1 receptor antagonists |
| CA2599778A1 (en) * | 2005-03-05 | 2006-09-14 | Bayer Healthcare Ag | Use of hydroxy tetrahydro-naphtalene derivates for the treatment of respiratory diseases |
| BRPI0608714A2 (pt) | 2005-03-19 | 2010-01-26 | Amorepacific Corp | compostos, isÈmeros dos mesmos, ou sais farmaceuticamente aceitáveis dos mesmos como antagonista do receptor vanilóide, e composições farmacêuticas contendo os mesmos |
| DE102005017286B3 (de) * | 2005-04-14 | 2006-12-28 | Schering Ag | Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| DE102005023943A1 (de) | 2005-05-20 | 2006-11-23 | Grünenthal GmbH | Pentafluorsulfanyl-substituierte Verbindung und deren Verwendung zur Herstellung von Arzneimitteln |
| EP2450346A1 (de) * | 2006-12-20 | 2012-05-09 | Abbott Laboratories | Antagonisten des RTPV1-Rezeptors und Verwendungen davon |
| WO2008096755A1 (ja) * | 2007-02-07 | 2008-08-14 | Nippon Suisan Kaisha, Ltd. | バニロイド受容体（ｖｒ１）阻害剤及びその用途 |
| DE102009055915A1 (de) * | 2009-11-27 | 2011-06-01 | Beiersdorf Ag | Verwendung von Zingeron zur Herstellung kosmetischer oder dermatologischer Zubereitungen, welche auf der Haut ein Prickeln hervorrufen |
| CN114206847B (zh) | 2019-08-23 | 2024-07-16 | 持田制药株式会社 | 杂环亚基乙酰胺衍生物的制造方法 |
| WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9713484D0 (en) | 1997-06-27 | 1997-09-03 | Smithkline Beecham Plc | Neuroprotective vanilloid compounds |
| US6333337B1 (en) * | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
| DE60024785T2 (de) * | 1999-02-22 | 2006-09-14 | Amorepacific Corp. | Vanilloid-analoge die resiniferatoxin-pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung |
| CA2369971A1 (en) | 1999-04-07 | 2000-10-19 | Sankyo Company, Limited | Aryl or heteroaryl fused imidazole derivatives, their pharmaceutical compositions and agents, and uses thereof |
| US6294694B1 (en) | 1999-06-04 | 2001-09-25 | Wisconsin Alumni Research Foundation | Matrix metalloproteinase inhibitors and method of using same |
| ES2291725T3 (es) * | 2002-12-06 | 2008-03-01 | Xention Limited | Derivados de tetrahidro-naftaleno. |
| EP1493438A1 (de) * | 2003-07-03 | 2005-01-05 | Bayer HealthCare AG | Inhibitoren des Vanilloid-Rezeptors (VR1) zur Behandlung von HIV-bedingten Schmerz |
| CA2542494A1 (en) * | 2003-10-15 | 2005-05-06 | Bayer Healthcare Ag | Tetrahydro-naphthalene and urea derivatives |
| US20080058377A1 (en) * | 2003-11-08 | 2008-03-06 | Bayer Healthcare Ag | Bicyclic Amide, Carbamate or Urea Derivatives as Vanilloid Receptor Modulators |
-
2003
- 2003-04-28 DK DK03722554T patent/DK1506167T3/da active
- 2003-04-28 ES ES03722554T patent/ES2292959T3/es not_active Expired - Lifetime
- 2003-04-28 AU AU2003229734A patent/AU2003229734B2/en not_active Expired
- 2003-04-28 CA CA2487238A patent/CA2487238C/en not_active Expired - Lifetime
- 2003-04-28 JP JP2004503441A patent/JP4335131B2/ja not_active Expired - Lifetime
- 2003-04-28 RU RU2004136281/04A patent/RU2331635C2/ru not_active IP Right Cessation
- 2003-04-28 PL PL373257A patent/PL210288B1/pl unknown
- 2003-04-28 NZ NZ536418A patent/NZ536418A/en not_active IP Right Cessation
- 2003-04-28 MX MXPA04010938A patent/MXPA04010938A/es active IP Right Grant
- 2003-04-28 EP EP03722554A patent/EP1506167B1/de not_active Expired - Lifetime
- 2003-04-28 WO PCT/EP2003/004395 patent/WO2003095420A1/en active IP Right Grant
- 2003-04-28 DE DE60315973T patent/DE60315973T2/de not_active Expired - Lifetime
- 2003-04-28 BR BR0309940-7A patent/BR0309940A/pt not_active IP Right Cessation
- 2003-04-28 US US10/513,848 patent/US7612113B2/en active Active
- 2003-04-28 AT AT03722554T patent/ATE371641T1/de active
- 2003-04-28 CN CNB038159880A patent/CN1307150C/zh not_active Expired - Lifetime
- 2003-05-07 TW TW092112380A patent/TWI271396B/zh not_active IP Right Cessation
-
2004
- 2004-11-03 IL IL165004A patent/IL165004A/en not_active IP Right Cessation
- 2004-12-07 NO NO20045359A patent/NO20045359L/no not_active Application Discontinuation
- 2004-12-07 HR HR20041167A patent/HRP20041167A2/xx not_active Application Discontinuation
-
2006
- 2006-03-02 HK HK06102754A patent/HK1082946A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2487238A1 (en) | 2003-11-20 |
| WO2003095420A1 (en) | 2003-11-20 |
| RU2004136281A (ru) | 2005-07-10 |
| NZ536418A (en) | 2006-04-28 |
| CN1665778A (zh) | 2005-09-07 |
| CN1307150C (zh) | 2007-03-28 |
| BR0309940A (pt) | 2005-02-09 |
| IL165004A0 (en) | 2005-12-18 |
| AU2003229734B2 (en) | 2009-02-19 |
| ES2292959T3 (es) | 2008-03-16 |
| DK1506167T3 (da) | 2008-01-02 |
| CA2487238C (en) | 2011-03-22 |
| JP4335131B2 (ja) | 2009-09-30 |
| NO20045359L (no) | 2004-12-07 |
| EP1506167B1 (de) | 2007-08-29 |
| AU2003229734A1 (en) | 2003-11-11 |
| DE60315973D1 (de) | 2007-10-11 |
| DE60315973T2 (de) | 2008-05-21 |
| PL210288B1 (pl) | 2011-12-30 |
| EP1506167A1 (de) | 2005-02-16 |
| JP2005524717A (ja) | 2005-08-18 |
| TW200404052A (en) | 2004-03-16 |
| US20060258742A1 (en) | 2006-11-16 |
| RU2331635C2 (ru) | 2008-08-20 |
| PL373257A1 (en) | 2005-08-22 |
| IL165004A (en) | 2010-12-30 |
| HRP20041167A2 (en) | 2005-08-31 |
| MXPA04010938A (es) | 2005-02-14 |
| US7612113B2 (en) | 2009-11-03 |
| TWI271396B (en) | 2007-01-21 |
| HK1082946A1 (en) | 2006-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1082946A1 (en) | Hydroxy tetrahydro-naphthalenyurea derivatives | |
| ATE370118T1 (de) | Tetrahydronaphtalen-derivate | |
| WO2003055848A3 (en) | Urea derivatives as vr1- antagonists | |
| WO2009109618A3 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 | |
| WO2004092115A3 (en) | Hydroxamates as therapeutic agents | |
| EA200970595A1 (ru) | Производные замещенных индазолов, активные в качестве ингибиторов киназ | |
| WO2003014064A8 (en) | Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists | |
| WO2009109616A8 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 | |
| CL2003002353A1 (es) | Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic | |
| WO2007053495A3 (en) | Compounds useful as antagonists of ccr2 | |
| EA200800147A1 (ru) | Способ получения олмесартан медоксомила | |
| WO2009109654A3 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40 | |
| DK1572632T3 (da) | Tetrahydro-naphthalenderivater som vanilloidreceptorantagonister | |
| CR10410A (es) | Carboxamidas sustituidas. | |
| WO2007053499A3 (en) | Compounds useful as antagonists of ccr2 | |
| GB2427405A (en) | Novel hydroxamates as therapeutic agents | |
| WO2005044802A3 (en) | Tetrahydro-quinolinylurea derivatives as vrl antagonists | |
| TW200716629A (en) | Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof | |
| MY155011A (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| WO2005035500A3 (en) | Therapeutic agents useful for treating pain | |
| TH78306B (th) | "อนุพันธ์ไฮดรอกซีเททตราไฮโดร-แนพธาลีนิลยูเรีย" | |
| EA200501765A3 (ru) | Средство для лечения болезней суставов | |
| EA200701086A1 (ru) | Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1506167 Country of ref document: EP |